Meta AnalysisID 897

三氯乙酸治疗睑黄瘤的有效性和安全性的系统评价

CRD42021227251

What is the efficacy and safety of trichloroacetic acid treatment in adults with xanthelasma palpebrarum?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
897
Evidence Id
9455
Core Evidence Id
9455
Source Meta Analysis Id
871
Herb2 Meta Analysis Id
HBMA000871
Crd Id
CRD42021227251
Title
Systematic review of the efficacy and safety of Trichloroacetic acid in the treatment of Xanthelasma Palpebrarum
Review Question
What is the efficacy and safety of trichloroacetic acid treatment in adults with xanthelasma palpebrarum?
Study Type Included
We will include randomized trials and observational studies (including cohort and case–control studies) to assess the beneficial effects of the treatments and assessment of harms.
Condition Being Studied
Xanthelasma palpebrarum is the most common cutaneous xanthoma. They most often occur in middle-aged and older adults and are associated with dyslipidemia in approximately 50% of the patients. Clinically, it presents as yellowish soft plaques or nodules that usually appear symmetrically on the medial side of the upper eyelids but can also involve the lower eyelids.
Participant
Inclusion: Adults with clinical diagnosis of xanthelasma palpebrarum. Exclusion: Under 18 years old, pregnancy and medical history of keloid or hypertrophic scar formation.
Animal
Human Disease Modelled
Intervention
Trichloroacetic acid treatment intervention is defined as the direct application of chlorinated acetic acid at different concentrations (30%-100% in one or more sessions) to xanthelasma palpebrarum lesions used as tissue cauterant that works by dissolving lipids and coagulating proteins.
Comparator Control
Usual care (Laser, cryotherapy, radiofrecuency or surgery)Laser. Destruction of perivascular foam cells via thermal energy damage and coagulation of dermal vessels leading to blockage of further lipid leakage into tissue. Cryotherapy. Ice crystal formation, thermal shock, enzyme inhibition, cellular dehydration and electrolyte disruption Radiofrequency ablation. Works by causing vaporization at a cellular level in tissues. It initiates fibrosis followed by volume reduction during healing. Surgery. Percutaneous excision of the lesions followed by direct suture.
Main Outcome
Efficacy defined as any clinical improvement after trichloroacetic acid application. Complete response: disappearance of the lesion. Partial response: cosmetic improvement of the lesion using a grading scale of clearance (>75%, 50–75%, 25–50% or <25% cleared). Safety. Benefits outweigh the possible risks for most people. Adverse effects: edema, pain, erythema, post-inflammatory hypo- or hyperpigmentation, crust formation and scarring. Measures of effect Clinical result ratio
Outcome Measure
Additional Outcome
Recurrence of lesion at 6 months after treatment with trichloroacetic acid application, laser, cryotherapy, radiofrequency ablation or surgery. Measures of effect Clinical result ratio
Study Method
Cost effectiveness, Intervention, Systematic review
Keyword
Eyelid Diseases; Humans; Trichloroacetic Acid; Xanthomatosis
Contact
Andrea Lopez Salmeron [email protected]
Organisational Affiliation
Centro Dermatologico Dr Ladislao de la Pascua
Funding Source
None Grant number(s) <span style=font-size: 14px>State the funder, grant or award number and the date of award</span> None
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
Mexico
Review Stage
Review Ongoing
First Submission Date
2020-12-19
Registration Date
2021-01-19
Anticipated Start Date
2020-12-23
Anticipated Completion Date
2021-12-23
Title Cn
三氯乙酸治疗睑黄瘤的有效性和安全性的系统评价
Title En
Systematic review of the efficacy and safety of Trichloroacetic acid in the treatment of Xanthelasma Palpebrarum
Bilingual Status
complete